← Open Payments lookup

PETER CHANG: Open Payments

NPI 1780688028 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,662 in 52 payments from 15 companies in 2025. Trend: 2023 $727 · 2024 $9,488 · 2025 $5,662

Consulting: $4,675Food & beverage: $967Education: $20
CompanyPaymentsAmount
ABBVIE INC.18$4,861
Ardelyx, Inc.11$388
Novo Nordisk Inc4$62
Neurocrine BioSciences, Inc.3$52
Axsome Therapeutics, Inc.3$51
Lilly USA, LLC2$44
Otsuka America Pharmaceutical, Inc.2$40
AstraZeneca Pharmaceuticals LP2$38
VERTEX PHARMACEUTICALS INCORPORATED1$25
Bayer Healthcare Pharmaceuticals Inc.1$20

Products named: XEN GLAUCOMA TREATMENT SYSTEM, DURYSTA, IBSRELA, VRAYLAR, UBRELVY, REXULTI, INGREZZA, Auvelity.

Industry payments across TX — which companies pay providers there.